NASDAQ: SWTX
Springworks Therapeutics Inc Stock Ownership - Who owns Springworks Therapeutics?

Insider buying vs selling

Have Springworks Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Saqib IslamChief Executive Officer2025-03-0311,600$55.15
$639.79kSell
Saqib IslamChief Executive Officer2025-03-031,400$56.13
$78.59kSell
Badreddin EdrisChief Operating Officer2025-03-033,598$55.12
$198.33kSell
Badreddin EdrisChief Operating Officer2025-03-0312,078$54.26
$655.33kSell
Badreddin EdrisChief Operating Officer2025-03-033,924$53.12
$208.45kSell
Saqib IslamChief Executive Officer2025-03-0311,800$52.97
$625.02kSell
Saqib IslamChief Executive Officer2025-03-0323,600$54.24
$1.28MSell
Saqib IslamChief Executive Officer2025-03-03600$56.89
$34.13kSell
Badreddin EdrisChief Operating Officer2025-03-03400$56.20
$22.48kSell
Saqib IslamChief Executive Officer2025-02-2730,756$53.41
$1.64MSell

1 of 8

SWTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SWTX insiders and whales buy or sell their stock.

SWTX Shareholders

What type of owners hold Springworks Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC17.36%13,006,149$601.40MInsider
Fmr LLC14.89%11,157,960$515.94MInstitution
Freda C. Lewishall11.51%8,625,759$398.86MInsider
Vanguard Group Inc9.55%7,158,871$331.03MInstitution
Stephen P. Squinto8.43%6,317,959$292.14MInsider
Blackrock Inc7.95%5,960,359$275.61MInstitution
Bain Capital Life Sciences Investors LLC6.45%4,832,413$223.45MInsider
Pfizer Inc6.13%4,593,847$212.42MInsider
Deep Track Capital LP4.62%3,460,756$160.03MInstitution
Boxer Capital Management LLC4.57%3,421,541$158.21MInstitution

1 of 3

SWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SWTX65.47%34.53%Net SellingNet Selling
SLNO30.26%69.74%Net SellingNet Selling
ZLAB5.21%1.75%Net SellingNet Selling
ACLX49.14%50.86%Net SellingNet Selling
RARE84.55%15.45%Net SellingNet Selling

Springworks Therapeutics Stock Ownership FAQ

Who owns Springworks Therapeutics?

Springworks Therapeutics (NASDAQ: SWTX) is owned by 107.93% institutional shareholders, 56.93% Springworks Therapeutics insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Springworks Therapeutics shareholder, owning 13.01M shares representing 17.36% of the company. Orbimed Advisors LLC's Springworks Therapeutics shares are currently valued at $602.18M.

If you're new to stock investing, here's how to buy Springworks Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.